EMGALITY galcanezumab 120mg/mL prefilled syringe

Eli Lilly Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 14d0a80b39a6d883
Product Name: EMGALITY galcanezumab 120mg/mL prefilled syringe
Artg Id: 302145
Artg Name: EMGALITY galcanezumab 120mg/mL prefilled syringe
Sponsor: Eli Lilly Australia Pty Ltd
Company Detail Path: /organization/eli-lilly-australia-pty-ltd
Artg Date: 2019-05-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01785-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01545-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

14d0a80b39a6d883

Type

Standard